Furthermore, luteolin promotes ferroptosis by upregulating heme oxygenase-1 (HO-1), resulting in heme degradation, increased free iron ions, mitochondrial dysfunction, and elevated reactive oxygen species (ROS) levels, ultimately leading to ferroptosis in RCC cells. Here, HMOX1 is linked to renal cell carcinoma.